Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

HBI Spotlight

 

What do the struggles of Australia’s private hospitals mean for private equity investors?

Private hospitals in Australia are facing a severe financial crisis, as highlighted by a recent Department of Health review. While the financial struggles of these hospitals are not new, this is the first time the government has conducted a review and officially acknowledged the issue. The review found that private hospital profit margins have nearly halved over five years as costs outpaced revenue, with “imminent closures” likely without urgent government intervention.

Preparing for the 2025 healthcare investment landscape — in conversation with Sharon Lamb, Partner at McDermott, Will & Emery

As the healthcare and life sciences sector emerges from a period of consolidation and slower deal activity, investors are eyeing 2025 with cautious optimism. HPE Europe, a conference hosted by multinational law firm McDermott, Will & Emery (MWE), convened in London this autumn to explore key investment themes and strategies for the year ahead, with HBI in attendance.

The HBI Top 100 largest groups in EMEA by revenue 2024 edition

Healthcare Business International has published its fourth annual ranking of EMEA's largest healthcare service providers, drawn from its database of over 5,000 operators. The list, which tracks EMEA-only healthcare service revenues, shows German hospital giant Fresenius Helios maintaining its market leadership with revenues of €12.3bn in 2023.

The UK and Europe set for increased PE investment and value chain consolidation in digital health — Rob Sher, Alvarez & Marsal

Europe, especially the UK, is seeing rising private equity interest and larger companies entering the digital health sector. Deal volumes are expected to grow as providers consolidate across the value chain.  The global digital health sector on the whole is increasingly attractive for private equity investments, with experts predicting a surge in M&A deals over the coming months.

Why pharma services is such an attractive investment space

Last week Telemos Capital, a European mid-market private equity firm backed by family capital, bought Helios Global Group, a full-service global healthcare communications provider, from NorthEdge, a regional lower mid-market private equity company. We spoke with one of the deal's advisors — Tom Cowap, Managing Director at Baird, an employee-owned international investment bank — about how this is a bellwether for growing private equity interest in the med comms and wider pharma services space.

2025 could be the year M&A finally bounces back

M&A activity in healthcare has been subdued over the past two and a half years. We discussed this with Ramesh Jassal, who has just joined investment bank Heligan Group as Partner ‑ Healthcare, Corporate Finance, to build a specialist healthcare advisory team. He shared his view on why we should expect to see deal activity return in 2025, and which sub sectors will see most interest.

Malaysia emerges as a preferred hub for healthcare PE investments

The Southeast Asian country Malaysia has recently witnessed a surge in private healthcare investments. This is particularly evident in the country’s top for-profit hospital provider IHH Healthcare’s latest acquisition of Island Hospital, a 600-bed private facility in Penang, Malaysia, for £970 million from the private equity (PE) firm Affinity Equity Partners. The Malaysian healthcare sector ripe for healthcare PE investments.

How occupational health captured the interest of private equity

Europe’s occupational health market is seeing growing interest from investors as employers across the continent become increasingly amenable to taking a proactive approach to supporting their employees’ health. The sector is beginning to see significant M&A and PE acquisitions.

Find Us